Lv51
1390 积分 2024-04-24 加入
Dupilumab treatment in adults with moderate-to-severe atopic dermatitis
2小时前
已完结
Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a randomised, placebo-controlled, dose-ranging phase 2b trial
2小时前
已完结
Natural history of relapsed myeloma, refractory to immunomodulatory drugs and proteasome inhibitors: a multicenter IMWG study
26天前
已完结
Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b/2 open-label study
26天前
已完结
T-cell malignancies following CAR T-Cell therapy: insights from the FDA Adverse Event Reporting System (FAERS)
1个月前
已完结
Post-marketing safety assessment of CAR T-cell therapies: Analysis of individual case safety reports in the VigiBase
1个月前
已完结
Real-world analysis of barriers to timely administration of chimeric antigen receptor T cell (CAR T) therapy in diffuse large B-cell lymphoma
1个月前
已完结
Itacitinib for the prevention of IEC therapy-associated CRS: Results from the 2-part phase 2 INCB 39110-211 study
1个月前
已完结
Graft-versus-host disease after anti-CD19 chimeric antigen receptor T-cell therapy following allogeneic hematopoietic cell transplantation: A transplant complications and paediatric diseases working parties joint EBMT study
1个月前
已完结
Simple and early prediction of severe CAR-T-related adverse events after axi-cel infusion by initial high fever
1个月前
已完结
皖公网安备34019202002308
